Reuters logo
BRIEF-‍Janssen-Cilag says European Commission approves expanded use of Zytiga
November 20, 2017 / 3:34 PM / a month ago

BRIEF-‍Janssen-Cilag says European Commission approves expanded use of Zytiga

Nov 20 (Reuters) - Janssen-Cilag International NV

* ‍Janssen-Cilag - European Commission has granted approval to broaden existing marketing authorisation for Zytiga plus prednisone / prednisolone​

* Janssen-Cilag - Approval broadens marketing authorisation to include an earlier stage of metastatic prostate cancer than its current indications​ Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below